CD8A and eye neoplasm: As several observations indicate that T cell production of IFNγ is not impaired within ocular tumors, CD8+ Treg may target macrophages in progressively growing ocular tumors to prevent their expression of inflammatory mediators that promote DTH responses which destroy the tumor vasculature, and/or directly kill tumor cells (Figure 6).